FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment.
Clin Nucl Med
; 32(10): 775-8, 2007 Oct.
Article
em En
| MEDLINE
| ID: mdl-17885356
ABSTRACT
We report 2 patients with chronic myeloid leukemia in the chronic phase showing diffusely increased F-18 fluorodeoxyglucose (FDG) uptake in the bone marrow before treatment. Follow-up FDG positron emission tomography (PET) scans were performed in a patient after cessation of treatment and in the other under treatment. Both FDG PET findings showed reduced FDG uptake in the bone marrow. A series of these FDG PET findings suggest the usefulness of FDG PET for the diagnosis and monitoring of chronic myeloid leukemia after treatment.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Piperazinas
/
Pirimidinas
/
Leucemia Mielogênica Crônica BCR-ABL Positiva
/
Fluordesoxiglucose F18
/
Tomografia por Emissão de Pósitrons
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article